284 related articles for article (PubMed ID: 15306231)
1. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression.
Jasmin JF; Mercier I; Hnasko R; Cheung MW; Tanowitz HB; Dupuis J; Lisanti MP
Cardiovasc Res; 2004 Sep; 63(4):747-55. PubMed ID: 15306231
[TBL] [Abstract][Full Text] [Related]
2. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 null (-/-) mice show dramatic reductions in life span.
Park DS; Cohen AW; Frank PG; Razani B; Lee H; Williams TM; Chandra M; Shirani J; De Souza AP; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
Biochemistry; 2003 Dec; 42(51):15124-31. PubMed ID: 14690422
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 deficiency increases cerebral ischemic injury.
Jasmin JF; Malhotra S; Singh Dhallu M; Mercier I; Rosenbaum DM; Lisanti MP
Circ Res; 2007 Mar; 100(5):721-9. PubMed ID: 17293479
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 deficiency stimulates neointima formation during vascular injury.
Hassan GS; Jasmin JF; Schubert W; Frank PG; Lisanti MP
Biochemistry; 2004 Jul; 43(26):8312-21. PubMed ID: 15222744
[TBL] [Abstract][Full Text] [Related]
6. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
Hnasko R; Lisanti MP
Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 and -2 in airway epithelium: expression and in situ association as detected by FRET-CLSM.
Krasteva G; Pfeil U; Drab M; Kummer W; König P
Respir Res; 2006 Aug; 7(1):108. PubMed ID: 16904002
[TBL] [Abstract][Full Text] [Related]
8. Disruption of endothelial-cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension.
Mathew R; Huang J; Shah M; Patel K; Gewitz M; Sehgal PB
Circulation; 2004 Sep; 110(11):1499-506. PubMed ID: 15353500
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived progenitor cells contribute to lung remodelling after myocardial infarction.
Dupuis J; Préfontaine A; Villeneuve L; Ruel N; Lefebvre F; Calderone A
Cardiovasc Pathol; 2007; 16(6):321-8. PubMed ID: 18005870
[TBL] [Abstract][Full Text] [Related]
10. Genetic ablation of caveolin-1 confers protection against atherosclerosis.
Frank PG; Lee H; Park DS; Tandon NN; Scherer PE; Lisanti MP
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):98-105. PubMed ID: 14563650
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy.
Selleri S; Arnaboldi F; Palazzo M; Hussein U; Balsari A; Rumio C
Br J Dermatol; 2005 Sep; 153(3):506-13. PubMed ID: 16120134
[TBL] [Abstract][Full Text] [Related]
12. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.
Zhao YY; Liu Y; Stan RV; Fan L; Gu Y; Dalton N; Chu PH; Peterson K; Ross J; Chien KR
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11375-80. PubMed ID: 12177436
[TBL] [Abstract][Full Text] [Related]
13. Helium postconditioning regulates expression of caveolin-1 and -3 and induces RISK pathway activation after ischaemia/reperfusion in cardiac tissue of rats.
Flick M; Albrecht M; Oei GTML; Steenstra R; Kerindongo RP; Zuurbier CJ; Patel HH; Hollmann MW; Preckel B; Weber NC
Eur J Pharmacol; 2016 Nov; 791():718-725. PubMed ID: 27742593
[TBL] [Abstract][Full Text] [Related]
14. Hepatic overexpression of caveolins increases bile salt secretion in mice.
Moreno M; Molina H; Amigo L; Zanlungo S; Arrese M; Rigotti A; Miquel JF
Hepatology; 2003 Dec; 38(6):1477-88. PubMed ID: 14647059
[TBL] [Abstract][Full Text] [Related]
15. The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium.
Wunderlich C; Schober K; Schmeisser A; Heerwagen C; Tausche AK; Steinbronn N; Brandt A; Kasper M; Schwencke C; Braun-Dullaeus RC; Strasser RH
J Mol Cell Cardiol; 2008 May; 44(5):938-47. PubMed ID: 18417152
[TBL] [Abstract][Full Text] [Related]
16. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
[TBL] [Abstract][Full Text] [Related]
17. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.
Capozza F; Williams TM; Schubert W; McClain S; Bouzahzah B; Sotgia F; Lisanti MP
Am J Pathol; 2003 Jun; 162(6):2029-39. PubMed ID: 12759258
[TBL] [Abstract][Full Text] [Related]
18. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27).
Wang XB; Lee H; Capozza F; Marmon S; Sotgia F; Brooks JW; Campos-Gonzalez R; Lisanti MP
Biochemistry; 2004 Nov; 43(43):13694-706. PubMed ID: 15504032
[TBL] [Abstract][Full Text] [Related]
20. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
Fraccarollo D; Widder JD; Galuppo P; Thum T; Tsikas D; Hoffmann M; Ruetten H; Ertl G; Bauersachs J
Circulation; 2008 Aug; 118(8):818-27. PubMed ID: 18678774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
